China Resources Pharmaceutical's (HKG:3320) unit KPC Pharmaceuticals obtained registration acceptance for a proposed bond issue from the National Association of Financial Market Institutional Investors.
The subsidiary can issue medium term bonds of up to 1 billion yuan in multiple tranches in China within two years of the notice, according to a Tuesday Hong Kong bourse filing.